Maxwell Biosciences: Funding, Investors & Team (Oct 2026)
Maxwell Biosciences is a company in the early stages of drug development, working on a new biotechnology platform called CLAROMER. This platform produces small compounds that imitate peptides and can easily enter cells, making them different from larger molecules.
Maxwell Biosciences has raised $30.8M across 2 funding rounds on record, the most recent an undisclosed round of $20.0M announced in Aug 2025.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Maxwell Biosciences Company Profile and Key Stats
Latest funding round on record: Aug 2025.
Maxwell Biosciences Funding Rounds
Maxwell Biosciences raised $10.8M in a Seed announced in Mar 2022.
3.4 years later, an undisclosed round of $20.0M was announced in Aug 2025.
Maxwell Biosciences Founders and Leadership Team
Contact details for the Maxwell Biosciences team: 1 of 1 has an email address on file.
Start 14-day free trial →Maxwell Biosciences Funding Compared to Other Biotechnology Startups
Maxwell Biosciences' latest round of $20.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Maxwell Biosciences in Biotechnology and Austin
Companies Similar to Maxwell Biosciences
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Maxwell Biosciences Funding FAQs
What does Maxwell Biosciences do?
Maxwell Biosciences is a company in the early stages of drug development, working on a new biotechnology platform called CLAROMER. This platform produces small compounds that imitate peptides and can easily enter cells, making them different from larger molecules.
How much funding has Maxwell Biosciences raised?
Maxwell Biosciences has raised $30.8M across 2 rounds on record. The most recent is an undisclosed round of $20.0M announced in Aug 2025.
When did Maxwell Biosciences last raise funding?
Maxwell Biosciences' most recent funding round on record is an undisclosed round of $20.0M, announced in Aug 2025.
Who founded Maxwell Biosciences?
FundedIQ lists Joshua Mcclure (Founder) at Maxwell Biosciences.
Where is Maxwell Biosciences headquartered?
Maxwell Biosciences is based in Austin, Texas, United States.
How many employees does Maxwell Biosciences have?
Maxwell Biosciences is in the 11-50 employee band.
How does Maxwell Biosciences' funding compare to other Biotechnology startups?
Maxwell Biosciences' latest round of $20.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Maxwell Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Maxwell Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.